Literature DB >> 28494859

HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue-Destructive Phenotype.

Nancy P Y Chung1, Xuemei Ou1, K M Faisal Khan1, Jacqueline Salit1, Robert J Kaner2, Ronald G Crystal3.   

Abstract

While highly active anti-retroviral therapy has dramatically improved the survival of HIV-infected individuals, there is an increased risk for other co-morbidities, such as COPD, manifesting as emphysema. Given that emphysema originates around the airways and that human airway basal cells (BCs) are adult airway stem/progenitor cells, we hypothesized that HIV reprograms BCs to a distinct phenotype that contributes to the development of emphysema. Our data indicate that HIV binds to but does not replicate in BCs. HIV binding to BCs induces them to acquire an invasive phenotype, mediated by upregulation of MMP-9 expression through activation of MAPK signaling pathways. This HIV-induced "destructive" phenotype may contribute to degradation of extracellular matrix and tissue damage relevant to the development of emphysema commonly seen in HIV+ individuals.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV; MMP-9; airway basal stem/progenitor cells; matrix metalloproteinase-9; reprogramming

Mesh:

Substances:

Year:  2017        PMID: 28494859      PMCID: PMC5521803          DOI: 10.1016/j.celrep.2017.04.026

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  73 in total

1.  Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.

Authors:  E L Murphy; A C Collier; L A Kalish; S F Assmann; M F Para; T P Flanigan; P N Kumar; L Mintz; F R Wallach; G J Nemo
Journal:  Ann Intern Med       Date:  2001-07-03       Impact factor: 25.391

Review 2.  The regulation of AP-1 activity by mitogen-activated protein kinases.

Authors:  M Karin
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

3.  HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation.

Authors:  I W Park; C K Ullrich; E Schoenberger; R K Ganju; J E Groopman
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

4.  Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.

Authors:  C Simon; H Goepfert; D Boyd
Journal:  Cancer Res       Date:  1998-03-15       Impact factor: 12.701

5.  Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins.

Authors:  Georgette D Kanmogne; Charles Primeaux; Paula Grammas
Journal:  Biochem Biophys Res Commun       Date:  2005-08-12       Impact factor: 3.575

6.  Up-regulation of alveolar macrophage matrix metalloproteinases in HIV1(+) smokers with early emphysema.

Authors:  Robert J Kaner; Francisco Santiago; Ronald G Crystal
Journal:  J Leukoc Biol       Date:  2009-07-15       Impact factor: 4.962

Review 7.  Acute kidney injury in HIV-infected patients.

Authors:  Sahir Kalim; Lynda A Szczech; Christina M Wyatt
Journal:  Semin Nephrol       Date:  2008-11       Impact factor: 5.299

8.  Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.

Authors:  H Sato; M Seiki
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

9.  Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B.

Authors:  M Bond; R P Fabunmi; A H Baker; A C Newby
Journal:  FEBS Lett       Date:  1998-09-11       Impact factor: 4.124

10.  Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era.

Authors:  M Patricia George; Mouhamed Kannass; Laurence Huang; Frank C Sciurba; Alison Morris
Journal:  PLoS One       Date:  2009-07-21       Impact factor: 3.240

View more
  7 in total

Review 1.  Chronic obstructive pulmonary disease in HIV.

Authors:  Katerina Byanova; Ken M Kunisaki; Joshua Vasquez; Laurence Huang
Journal:  Expert Rev Respir Med       Date:  2020-11-23       Impact factor: 3.772

2.  Acute Human Immunodeficiency Virus (HIV) Infection Presenting With Bilateral Interstitial Pneumonia: Case Report and Discussion of Potential HIV-Induced Interstitial Pneumonia.

Authors:  Anna Maria Peri; Laura Alagna; Serena Trovati; Francesca Sabbatini; Roberto Rona; Francesco Roberto Simonetti; Sergio Foresti; Guglielmo Marco Migliorino; Andrea Gori; Alessandra Bandera
Journal:  Open Forum Infect Dis       Date:  2017-11-20       Impact factor: 3.835

3.  Decreased microbiome diversity in the HIV small airway epithelium.

Authors:  Stella Xu; Amy Tsai; Marc A Sze; Emily A Vucic; Tawimas Shaipanich; Marianne Harris; Silvia Guillemi; Julia Yang; Sunita Sinha; Corey Nislow; Julio Montaner; Wan Lam; Stephen Lam; Don D Sin; S F Paul Man; Janice M Leung
Journal:  Respir Res       Date:  2018-07-27

4.  HIV induces airway basal progenitor cells to adopt an inflammatory phenotype.

Authors:  Nancy P Y Chung; K M Faisal Khan; Robert J Kaner; Sarah L O'Beirne; Ronald G Crystal
Journal:  Sci Rep       Date:  2021-02-17       Impact factor: 4.379

5.  Impaired differentiation of small airway basal stem/progenitor cells in people living with HIV.

Authors:  Nancy P Y Chung; K M Faisal Khan; Mirko Andreoli; Robert J Kaner; Sarah L O'Beirne; Ronald G Crystal
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.379

6.  Decreased telomere length in the small airway epithelium suggests accelerated aging in the lungs of persons living with human immunodeficiency virus (HIV).

Authors:  Stella Xu; Emily A Vucic; Tawimas Shaipanich; Stephen Lam; Wan Lam; Julio S Montaner; Don D Sin; S F Paul Man; Janice M Leung
Journal:  Respir Res       Date:  2018-06-13

Review 7.  Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection.

Authors:  Yulia Alexandrova; Cecilia T Costiniuk; Mohammad-Ali Jenabian
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.